HAMMAN-RICH SYNDROME – THE FIRST DESCRIBED CASE REPORT USING EXTRACORPOREAL MEMBRANE OXYGENATION (ECMO) SUPPORT

2011 ◽  
Vol 22 ◽  
pp. S107
Author(s):  
Marta Couto ◽  
Ana Freitas ◽  
Ana Cunha ◽  
Elisabete Monteiro ◽  
Roberto Roncon-Albuquerque ◽  
...  
Keyword(s):  
Case Report ◽  
Extracorporeal Membrane Oxygenation ◽  
Ecmo Support ◽  
Membrane Oxygenation

scholarly journals Suspected Heparin-Induced Thrombocytopenia in a COVID-19 Patient on Extracorporeal Membrane Oxygenation Support: A Case Report.

2020 ◽  
Author(s):  
Xuan T. Phan ◽  
Tuan Huu Nguyen ◽  
Tung T. Tran ◽  
Thu-Hien T. Huynh ◽  
Thuy-Ha T. Hoang ◽  
...  
Keyword(s):  
Case Report ◽  
Adverse Events ◽  
Extracorporeal Membrane Oxygenation ◽  
Ecmo Support ◽  
Specific Situation ◽  
Heparin Induced Thrombocytopenia ◽  
Case Presentation ◽  
Membrane Oxygenation ◽  
Life Saving ◽  
Number Of Patients

Abstract Background: Extracorporeal membrane oxygenation (ECMO) support can be life-saving in critically ill COVID-19 patients. However, there are many complications associated with this procedure, including Heparin-induced thrombocytopenia (HIT.) Despite its rarity in ECMO cases, HIT can lead to devastating consequences and is difficult to manage. Case presentation: In this report, we present a case of a COVID-19 patient on ECMO support who was diagnosed with HIT and required intensive treatment. Initially, HIT was only suspected due to newly-developed thrombocytopenia and oxygenator dysfunction, with thrombi observed later. Regarding his treatment, since there was no recommended replacement to heparin available to us at the time of diagnosis, we decided to use rivaroxaban temporarily. No adverse events were recorded during that period. The patient was able to make a full recovery.Conclusion: HIT may jeopardize patient’s care during ECMO. As COVID-19 may bring about a surge in the number of patients requiring ECMO support, we need consented guidance to optimize treatment in this specific situation.

scholarly journals Suspected Heparin-Induced Thrombocytopenia in a COVID-19 Patient on Extracorporeal Membrane Oxygenation Support: A Case Report.

2020 ◽  
Author(s):  
Xuan T. Phan ◽  
Tuan Huu Nguyen ◽  
Tung T. Tran ◽  
Thu-Hien T. Huynh ◽  
Thuy-Ha T. Hoang ◽  
...  
Keyword(s):  
Case Report ◽  
Adverse Events ◽  
Extracorporeal Membrane Oxygenation ◽  
Ecmo Support ◽  
Specific Situation ◽  
Heparin Induced Thrombocytopenia ◽  
Case Presentation ◽  
Membrane Oxygenation ◽  
Life Saving ◽  
Number Of Patients

Abstract Background: Extracorporeal membrane oxygenation (ECMO) support can be life-saving in critically ill COVID-19 patients. However, there are many complications associated with this procedure, including Heparin-induced thrombocytopenia (HIT.) Despite its rarity in ECMO cases, HIT can lead to devastating consequences and is difficult to manage. Case presentation: In this report, we present a case of a COVID-19 patient on ECMO support who was diagnosed with HIT and required intensive treatment. Initially, HIT was only suspected due to newly-developed thrombocytopenia and oxygenator dysfunction, with thrombi observed later. Regarding his treatment, since there was no recommended replacement to heparin available to us at the time of diagnosis, we decided to use rivaroxaban temporarily. No adverse events were recorded during that period. The patient was able to make a full recovery. Conclusion: HIT may jeopardize patient’s care during ECMO. As COVID-19 may bring about a surge in the number of patients requiring ECMO support, we need consented guidance to optimize treatment in this specific situation.

scholarly journals Suspected heparin-induced thrombocytopenia in a COVID-19 patient on extracorporeal membrane oxygenation support: a case report

2020 ◽  
Vol 18 (1) ◽  
Author(s):  
Xuan T. Phan ◽  
Tuan H. Nguyen ◽  
Tung T. Tran ◽  
Thu-Hien T. Huynh ◽  
Thuy-Ha T. Hoang ◽  
...  
Keyword(s):  
Case Report ◽  
Adverse Events ◽  
Extracorporeal Membrane Oxygenation ◽  
Ecmo Support ◽  
Specific Situation ◽  
Heparin Induced Thrombocytopenia ◽  
Case Presentation ◽  
Membrane Oxygenation ◽  
Life Saving ◽  
Number Of Patients

Abstract Background Extracorporeal membrane oxygenation (ECMO) support can be life-saving in critically ill COVID-19 patients. However, there are many complications associated with this procedure, including Heparin-induced thrombocytopenia (HIT.) Despite its rarity in ECMO cases, HIT can lead to devastating consequences and is difficult to manage. Case presentation In this report, we present a case of a COVID-19 patient on ECMO support who was diagnosed with HIT and required intensive treatment. Initially, HIT was only suspected due to newly-developed thrombocytopenia and oxygenator dysfunction, with thrombi observed later. Regarding his treatment, since there was no recommended replacement to heparin available to us at the time of diagnosis, we decided to use rivaroxaban temporarily. No adverse events were recorded during that period. The patient was able to make a full recovery. Conclusion HIT may jeopardize patient’s care during ECMO. As COVID-19 may bring about a surge in the number of patients requiring ECMO support, we need consented guidance to optimize treatment in this specific situation.

scholarly journals Suspected Heparin-Induced Thrombocytopenia in a COVID-19 Patient on Extracorporeal Membrane Oxygenation Support: A Case Report.

2020 ◽  
Author(s):  
Xuan T. Phan ◽  
Tuan Huu Nguyen ◽  
Tung T. Tran ◽  
Thu-Hien T. Huynh ◽  
Thuy-Ha T. Hoang ◽  
...  
Keyword(s):  
Case Report ◽  
Adverse Events ◽  
Extracorporeal Membrane Oxygenation ◽  
Ecmo Support ◽  
Specific Situation ◽  
Heparin Induced Thrombocytopenia ◽  
Case Presentation ◽  
Membrane Oxygenation ◽  
Life Saving ◽  
Number Of Patients

Abstract Background: Extracorporeal membrane oxygenation (ECMO) support can be life-saving in critically ill COVID-19 patients. However, there are many complications associated with this procedure, including Heparin-induced thrombocytopenia (HIT.) Despite its rarity in ECMO cases, HIT can lead to devastating consequences and is difficult to manage. Case presentation: In this report, we present a case of a COVID-19 patient on ECMO support who was diagnosed with HIT and required intensive treatment. Initially, HIT was only suspected due to newly-developed thrombocytopenia and oxygenator dysfunction, with thrombi observed later. Regarding his treatment, since there was no recommended replacement to heparin available to us at the time of diagnosis, we decided to use rivaroxaban temporarily. No adverse events were recorded during that period. The patient was able to make a full recovery.Conclusion: HIT may jeopardize patient’s care during ECMO. As COVID-19 may bring about a surge in the number of patients requiring ECMO support, we need consented guidance to optimize treatment in this specific situation.

scholarly journals Suspected Heparin-Induced Thrombocytopenia in a COVID-19 Patient on Extracorporeal Membrane Oxygenation Support: A Case Report.

2020 ◽  
Author(s):  
Xuan T. Phan ◽  
Tuan Huu Nguyen ◽  
Tung T. Tran ◽  
Thu-Hien T. Huynh ◽  
Thuy-Ha T. Hoang ◽  
...  
Keyword(s):  
Case Report ◽  
Adverse Events ◽  
Extracorporeal Membrane Oxygenation ◽  
Ecmo Support ◽  
Specific Situation ◽  
Heparin Induced Thrombocytopenia ◽  
Case Presentation ◽  
Membrane Oxygenation ◽  
Life Saving ◽  
Number Of Patients

Abstract Background: Extracorporeal membrane oxygenation (ECMO) support can be life-saving in critically ill COVID-19 patients. However, there are many complications associated with this procedure, including Heparin-induced thrombocytopenia (HIT.) Despite its rarity in ECMO cases, HIT can lead to devastating consequences and is difficult to manage.Case presentation: In this report, we present a case of a COVID-19 patient on ECMO support who was diagnosed with HIT and required intensive treatment. Initially, the patient showed no remarkable sign of thrombosis and HIT was only suspected due to newly-developed thrombocytopenia and oxygenator dysfunction. Regarding his treatment, since there was no recommended replacement to heparin available to us at the time of diagnosis, we decided to use Rivaroxaban temporarily. No adverse events were recorded during that period. The patient was able to make a full recovery.Conclusion: HIT may jeopardize patient’s care during ECMO. As COVID-19 may bring about a surge in the number of patients requiring ECMO support, we need consented guidance to optimize treatment in this specific situation.

The effects of propofol on extracorporeal membrane oxygenation oxygenator exchange

2021 ◽  
pp. 039139882110160
Author(s):  
Kelsey L Browder ◽  
Ayesha Ather ◽  
Komal A Pandya
Keyword(s):  
Cohort Study ◽  
Extracorporeal Membrane Oxygenation ◽  
Cumulative Dose ◽  
Retrospective Cohort Study ◽  
Retrospective Cohort ◽  
Primary Outcome ◽  
Ecmo Support ◽  
Single Center ◽  
Membrane Oxygenation ◽  
Vv Ecmo

The objective of this study was to determine if propofol administration to veno-venous (VV) extracorporeal membrane oxygenation (ECMO) patients was associated with more incidents of oxygenator failure when compared to patients who did not receive propofol. This was a single center, retrospective cohort study. The primary outcome of the study is oxygenator exchanges per ECMO day in patients who received propofol versus those who did not receive propofol. Patients were 18 years or older on VV-ECMO support between January 1, 2015 and January 31, 2018. Patients were excluded if they required ECMO support for less than 48 h or greater than 21 days. There were five patients in the propofol arm that required oxygenator exchanges and seven patients in the control arm. The total number of oxygenator exchanges per ECMO day was not significantly different between groups ( p = 0.50). When comparing those who required an oxygenator exchange and those who did not, there was no difference in the cumulative dose of propofol received per ECMO hour (0.64 mg/kg/h vs 0.96 mg/kg/h; p = 0.16). Propofol use in patients on VV-ECMO does not appear to increase the number of oxygenator exchanges.

Sign in / Sign up

Export Citation Format

Share Document